OPKO Health has been awarded a $1 million grant from the Bill & Melinda Gates Foundation to support the development of a diagnostic test to distinguish between latent tuberculosis and active tuberculosis utilizing OPKO’s proprietary molecular diagnostics technology. Utilizing its proprietary technology, OPKO is developing simple blood tests to identify biomarkers for a wide variety of diseases, including neurodegenerative disorders and various malignancies.

Leave a Reply

Your email address will not be published. Required fields are marked *